title: Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
abstract: OBJECTIVE
  We investigated the relationship between cyclin E mRNA overexpression and p53 protein accumulation in epithelial ovarian cancers.
  
  
  METHODS
  mRNA was isolated and cDNA was prepared from 36 epithelial ovarian tumors (three adenomas, three low malignant potential tumors, and 30 carcinomas), and six normal ovaries. The cyclin E mRNA expression levels relative to an internal control, beta-tubulin, were determined by semiquantitative polymerase chain reaction (PCR). Cyclin E and p53 protein expression in ovarian cancer tissues were examined by immunohistochemistry using the same series of samples. Fisher exact test of significance and an unpaired t test were used for statistical analysis.
  
  
  RESULTS
  Considerable levels of cyclin E mRNA were detected in all normal ovaries and ovarian tumor samples examined by semiquantitative PCR amplification. mRNA levels of cyclin E were significantly higher in nine of 30 (30%) ovarian cancers compared with those in normal ovaries. The immunohistochemical expression of cyclin E protein was confirmed in the nuclei of tumor cells in 13 of 30 (43%) ovarian cancers. p53 protein accumulation was detected in 12 of 30 (40%) ovarian cancers examined. There was a significant inverse correlation between cyclin E mRNA overexpression and p53 protein accumulation (P <.01, Fisher exact test).
  
  
  CONCLUSIONS
  Cyclin E mRNA overexpression frequently occurs in ovarian cancers without p53 protein accumulation. Cyclin E might have an important effect on the development of a limited number of ovarian cancers.
authors.affiliation: Department of Obstetrics and Gynecology, Kure National Hospital, Chugoku Cancer Center, Kure, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Sawasaki
authors.forename: K
authors.initials: K
authors.lastname: Shigemasa
authors.forename: Y
authors.initials: Y
authors.lastname: Shiroyama
authors.forename: T
authors.initials: T
authors.lastname: Kusuda
authors.forename: T
authors.initials: T
authors.lastname: Fujii
authors.forename: T H
authors.initials: TH
authors.lastname: Parmley
authors.forename: T J
authors.initials: TJ
authors.lastname: O'Brien
authors.forename: K
authors.initials: K
authors.lastname: Ohama
mesh_terms: D000236:Adenoma / Q000737:chemistry / Q000378:metabolism*; D002277:Carcinoma / Q000378:metabolism*; D019927:Cyclin E / Q000032:analysis / Q000235:genetics*; D005260:Female; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry; D010051:Ovarian Neoplasms / Q000737:chemistry / Q000378:metabolism*; D010053:Ovary / Q000737:chemistry; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis; D014404:Tubulin / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry / Q000378:metabolism*
chemical_list: D019927:Cyclin E; D012333:RNA, Messenger; D014404:Tubulin; D016159:Tumor Suppressor Protein p53